Machine Learning-Based Risk Stratification of Procedural and Ischemic Outcomes in Prediabetic Patients Undergoing Chronic Total Occlusion Interventions
Keywords:
machine learning; risk stratification; prediabetes; chronic total occlusion; percutaneous coronary intervention; fairness; clinical governanceAbstract
Prediabetic patients undergoing percutaneous coronary intervention for chronic total occlusion represent a clinically challenging population with elevated procedural complexity and ambiguous ischemic risk. Traditional regression-based risk models often fail to capture the nonlinear interactions among glycemic status, lesion anatomy, operator technique, and institutional factors. This paper examines the design and deployment of machine learning systems for risk stratification in this setting from a socio-technical and systems perspective. It argues that algorithmic accuracy must be embedded within a broader architecture that includes data governance, interoperable infrastructure, model interpretability, fairness, workflow integration, and longitudinal monitoring. The discussion covers cohort characterization, missing data handling, model selection, validation, deployment, sustainability, and policy implications. A recent national inpatient sample study reporting a paradoxical mortality benefit but increased procedural and ischemic risk in prediabetic chronic total occlusion is considered as an illustration of outcome complexity. The paper highlights structural trade-offs between centralized and federated learning, between model complexity and clinical explainability, and between performance optimization and equity. It concludes that sustainable clinical machine learning systems require robust governance mechanisms, standardized outcome definitions, prospective evaluation, and regulatory alignment to support safe decision-making in interventional cardiology.
References
1. Rajkomar, A., Dean, J., & Kohane, I. (2019). Machine learning in medicine. New England Journal of Medicine, 380(14), 1347–1358.
2. Topol, E. J. (2019). High-performance medicine: the convergence of human and artificial intelligence. Nature Medicine, 25(1), 44–56.
3. Obermeyer, Z., Powers, B., Vogeli, C., & Mullainathan, S. (2019). Dissecting racial bias in an algorithm used to manage the health of populations. Science, 366(6464), 447–453.
4. Wiens, J., Saria, S., Sendak, M., Ghassemi, M., Liu, V. X., Doshi-Velez, F., ... & Goldenberg, A. (2019). Do no harm: a roadmap for responsible machine learning for health care. Nature Medicine, 25(9), 1337–1340.
5. Johnson, A. E. W., Pollard, T. J., Shen, L., Lehman, L. H., Feng, M., Ghassemi, M., ... & Mark, R. G. (2016). MIMIC-III, a freely accessible critical care database. Scientific Data, 3, 160035.
6. Brilakis, E. S., Grantham, J. A., Rinfret, S., Wyman, R. M., Burke, M. N., Karmpaliotis, D., ... & Lombardi, W. L. (2012). A percutaneous treatment algorithm for crossing coronary chronic total occlusions. JACC: Cardiovascular Interventions, 5(4), 367–379.
7. Brilakis, E. S., Banerjee, S., Karmpaliotis, D., Lombardi, W. L., Tsai, T. T., Shunk, K. A., ... & Grantham, J. A. (2015). Procedural outcomes of chronic total occlusion percutaneous coronary intervention: a report from the NCDR. JACC: Cardiovascular Interventions, 8(2), 245–253.
8. Maeremans, J., Walsh, S., Knaapen, P., Spratt, J. C., Avran, A., Hanratty, C. G., ... & Dens, J. (2016). The hybrid algorithm for treating chronic total occlusions in Europe: the RECHARGE registry. Journal of the American College of Cardiology, 68(18), 1958–1970.
9. Christakopoulos, G. E., Christopoulos, G., Carlino, M., Jeroudi, O. M., Roesle, M., Rangan, B. V., ... & Brilakis, E. S. (2015). Meta-analysis of clinical outcomes of patients who underwent percutaneous coronary interventions for chronic total occlusions. American Journal of Cardiology, 115(10), 1367–1375.
10. Sterne, J. A. C., White, I. R., Carlin, J. B., Spratt, M., Royston, P., Kenward, M. G., ... & Carpenter, J. R. (2009). Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ, 338, b2393.
11. Collins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015). Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): the TRIPOD statement. Annals of Internal Medicine, 162(1), 55–63.
12. Riley, R. D., Ensor, J., Snell, K. I. E., Harrell, F. E., Martin, G. P., Reitsma, J. B., ... & van Smeden, M. (2020). Calculating the sample size required for developing a clinical prediction model. BMJ, 368, m441.
13. Kelly, C. J., Karthikesalingam, A., Suleyman, M., Corrado, G., & King, D. (2019). Key challenges for delivering clinical impact with artificial intelligence. BMC Medicine, 17(1), 195.
14. Shah, N. H., Milstein, A., & Bagley, S. C. (2019). Making machine learning models clinically useful. JAMA, 322(14), 1351–1352.
15. Hicks, K. A., Mahaffey, K. W., Mehran, R., Nissen, S. E., Wiviott, S. D., Dunn, B., ... & Temple, R. (2018). 2017 cardiovascular and stroke endpoint definitions for clinical trials. Circulation, 137(9), 961–972.
16. Li, A., Mondal, A., Balogun, A. S., Patel, P. V., Kaulback, K. W., Farmer, A., & Lin, Z. (2025). Paradoxical mortality benefit but increased procedural and ischemic risk in prediabetic chronic total occlusion: a national inpatient sample study. BMC Cardiovascular Disorders, 26(1), 38.
17. Chen, T., & Guestrin, C. (2016). XGBoost: a scalable tree boosting system. In Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining (pp. 785–794). ACM.
18. Lundberg, S. M., & Lee, S. I. (2017). A unified approach to interpreting model predictions. In Advances in Neural Information Processing Systems (Vol. 30, pp. 4765–4774).
19. Rieke, N., Hancox, J., Li, W., Milletarì, F., Roth, H. R., Albarqouni, S., ... & Cardoso, M. J. (2020). The future of digital health with federated learning. NPJ Digital Medicine, 3, 119.
20. Floridi, L., Cowls, J., Beltrametti, M., Chatila, R., Chazerand, P., Dignum, V., ... & Vayena, E. (2018). AI4People—An ethical framework for a good AI society: opportunities, risks, principles, and recommendations. Minds and Machines, 28(4), 689–707.
21. Char, D. S., Shah, N. H., & Magnus, D. (2018). Implementing machine learning in health care—addressing ethical challenges. New England Journal of Medicine, 378(11), 981–983.
22. National Academy of Medicine. (2019). Artificial intelligence in health care: The hope, the hype, the promise, the peril. The National Academies Press. https://doi.org/10.17226/27111
23. Chen, I. Y., Pierson, E., Rose, S., Joshi, S., Ferryman, K., & Ghassemi, M. (2021). Ethical machine learning in health care. Annual Review of Biomedical Data Science, 4, 123–144.
24. Wijns, W., Naber, C. K., Reiber, J. H. C., Mohr, F. W., Gershlick, A. H., Sousa-Uva, M., ... & Kolh, P. (2019). 2018 ESC/EACTS guidelines on myocardial revascularization. European Heart Journal, 40(2), 87–165.
25. Steyerberg, E. W., Vickers, A. J., Cook, N. R., Gerds, T., Gonen, M., Obuchowski, N., ... & Kattan, M. W. (2010). Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology, 21(1), 128–138.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 International Journal of Clinical and Translational Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
This article is published under the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
